JThe following companies are expected to report earnings before the market opens on 03/14/2022. See our results calendar for a full list of expected results releases.

Whole Earth Brands, Inc. (FREE) reports for the quarter ending December 31, 2021. The consumer company’s consensus earnings per share forecast from the 1 analyst tracking the stock is $0.31. This value represents an increase of 338.46% compared to the same quarter last year. The “days to cover” for this stock exceeds 13 days. Zacks Investment Research reports that the 2021 FREE Price to Earnings Ratio is 9.52 vs. an industry ratio of -18.30, implying that they will have higher earnings growth than their competitors in the same industry.

Adaptimmune Therapeutics plc (ADAP) reports for the quarter ending December 31, 2021. The consensus earnings per share forecast for the biomedical company (gene) from the 2 analysts who track the stock is -$0.22. This value represents an increase of 8.33% compared to the same quarter last year. ADAP missed consensus Q4 calendar 2020 earnings per share by -4.35%. Zacks Investment Research reports that the 2021 P/E ratio for ADAP is -3.71 versus an industry ratio of -0.20.

Luna Innovations Incorporated (LUNA) reports for the quarter ending Dec. 31, 2021. The technology services company‘s consensus earnings per share forecast from the 2 analysts who track the stock is $0.03. This value represents a decrease of 57.14% compared to the same quarter last year. The “days to cover” for this stock exceeds 10 days. Zacks Investment Research reports that the 2021 price-to-earnings ratio for LUNA is 167.00 versus an industry ratio of 2.80, implying that they will have higher earnings growth than their competitors in the same industry.

AVEO Pharmaceuticals, Inc. (AVEO) releases its report for the quarter ending December 31, 2021. The consensus earnings per share forecast for the biomedical company (gene) from the 2 analysts who track the stock is -$0.35. This value represents an increase of 20.45% compared to the same quarter last year. Zacks Investment Research reports that the 2021 price-to-earnings ratio for AVEO is -2.24 versus an industry ratio of -0.20.

CareCloud, Inc. (MTBC) reports for the quarter ending Dec. 31, 2021. The medical information systems company’s consensus earnings per share forecast from the 2 analysts who track the stock is -$0.17. This value represents a decrease of 1,800.00% compared to the same quarter last year. MTBC missed consensus earnings per share in the 2nd calendar quarter of 2021 by -8%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for MTBC is -5.81 versus an industry ratio of -1.90.

Biodesix, Inc. (BDSX) reports for the quarter ending December 31, 2021. The medical services company’s consensus earnings-per-share forecast from the 2 analysts who track the stock is -$0.50. This value represents a decrease of 100.00% compared to the same quarter last year. Zacks Investment Research reports that the 2021 P/E ratio for BDSX is -1.40 versus an industry ratio of 14.70.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.